Rxsight Inc 's ability to collect accounts receivable sequentially worsen to 3.44, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Rxsight Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 106 days, from 70 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 334 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2217 to 2294.

What is Receivable Turnover Ratio?
What is Rxsight Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RXST Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	179.85 %	-27.51 %	-22.19 %	-4.8 %	9.08 %
Y / Y Revenue Change	1.66 %	-18.3 %	-18.45 %	-14.18 %	-3.09 %
Receivable Turnover Ratio (TTM)	3.44	5.19	5.03	5	5.12
RXST's Total Ranking	# 2294	# 2217	# 1989	# 2480	# 2328
Accounts Receivable average collection period days	106	70	73	73	71
Seq. Receivable Change	249.86 %	-4.02 %	-3.18 %	-13.92 %	-9.37 %
Seq. Revenue Change	10.63 %	-8.31 %	10.04 %	-8.93 %	-11.09 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 138
Healthcare Sector	# 335
Overall Market	# 2294

Receivable Turnover Ratio Statistics
High	Average	Low
0.54	0.39	0.15
(Mar 31 2024)		(Dec 31 2021)

RXST Company Profile • Back to RXST Efficiency Comparisons • Compare RXST Receivables Turnover Ratio to its Competitors

Financial Statements
Rxsight Inc 's Accounts Receivable	$ 79 Millions	Visit RXST's Balance sheet
Rxsight Inc 's Sales TTM	$ 128 Millions	Visit RXST's Income Statement
Sources of RXST's Revenues		Visit RXST's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RXST's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RXST's Growth Rates	RXST's Roa	RXST's Inventory Turnover Ratio	RXST's Dividend Comparisons
RXST's Profitability Ratios	RXST's Roi	RXST's Asset Turnover Ratio	RXST's Dividend Growth
RXST's Valuation Ratios	RXST's Roe	RXST's Financial Strength Ratios	RXST's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Fulgent Genetics Inc	4.45	$ 322.973 Millions	$ 72.541 Millions
Gyre Therapeutics Inc	4.43	$ 119.383 Millions	$ 26.928 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	4.42	$ 25.185 Millions	$ 5.695 Millions
Supernus Pharmaceuticals inc	4.41	$ 830.438 Millions	$ 188.224 Millions
Eli Lilly And Company	4.40	$ 79,665.800 Millions	$ 18,094.850 Millions
Neurocrine Biosciences Inc	4.40	$ 3,373.900 Millions	$ 767.475 Millions
Lantheus Holdings Inc	4.39	$ 1,555.343 Millions	$ 354.642 Millions
Waters Corporation	4.38	$ 4,644.249 Millions	$ 1,059.341 Millions
Organon and Co	4.31	$ 6,139.000 Millions	$ 1,422.750 Millions
Vsee Health Inc	4.30	$ 10.759 Millions	$ 2.500 Millions
Alkermes Plc	4.30	$ 1,667.652 Millions	$ 388.132 Millions
Glaukos Corp	4.29	$ 500.031 Millions	$ 116.471 Millions
Dexcom Inc	4.25	$ 4,968.800 Millions	$ 1,168.000 Millions
Vericel Corporation	4.18	$ 306.303 Millions	$ 73.289 Millions
Retractable Technologies Inc	4.14	$ 33.488 Millions	$ 8.087 Millions
Apyx Medical Corp	4.14	$ 58.105 Millions	$ 14.035 Millions
Regenxbio Inc	4.13	$ 174.482 Millions	$ 42.238 Millions
Revvity Inc	4.12	$ 2,911.811 Millions	$ 706.371 Millions
Pro dex Inc	4.12	$ 77.548 Millions	$ 18.836 Millions
Stoke Therapeutics Inc	4.12	$ 27.588 Millions	$ 6.704 Millions
Medinotec Inc	4.08	$ 10.247 Millions	$ 2.513 Millions
Amgen Inc	4.07	$ 38,095.000 Millions	$ 9,356.250 Millions
Nexalin Technology Inc	4.07	$ 0.217 Millions	$ 0.053 Millions
Outset Medical Inc	4.06	$ 117.551 Millions	$ 28.959 Millions
Butterfly Network Inc	4.05	$ 112.360 Millions	$ 27.732 Millions
Ironwood Pharmaceuticals inc	4.04	$ 389.316 Millions	$ 96.422 Millions
Pelthos Therapeutics Inc	4.03	$ 43.304 Millions	$ 10.757 Millions
Upstream Bio Inc	4.00	$ 3.158 Millions	$ 0.789 Millions
Skinvisible Inc	4.00	$ 0.020 Millions	$ 0.005 Millions
Xencor Inc	3.99	$ 104.973 Millions	$ 26.335 Millions

Date modified: 2026-09-11T09:46:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.